Delin Ventures
ActiveOverview
Delin Ventures is a UK-based venture capital firm established in 2015, specializing in early-stage investments in Life Sciences and the Future of Work & Learning.123 It focuses on pre-seed and seed rounds for European startups, with ticket sizes from €100,000 to €1.5 million, providing hands-on support, operational expertise, and patient capital to portfolio companies.12 The firm is led by founder Igor Linshits and emphasizes high-quality, selective investments in breakthrough technologies for healthcare transformation and workforce development.1
History
Delin Ventures was established in 2015 by Igor Linshits as a mission-driven VC firm targeting early-stage investments in Life Sciences and Future of Work & Learning.1 It invests primarily in European startups, backing founders in cell therapies, therapeutics, manufacturing technologies, HR tech, and productivity tools.12 Notable portfolio companies include Fluidic Analytics, Vidsy, and Ori Biotech, with the last investment recorded in July 2023.1
Notable Products
- Life Sciences Fund - Invests in and builds cell therapy companies focusing on therapeutics, services, and manufacturing technologies for scalability and commercial viability.
- Future of Work & Learning investments - Backs technologies in HR tech, productivity tools, workforce development, and upskilling platforms to shape tomorrow's workforce.
Reputation
Delin Ventures is perceived as a selective, hands-on investor with deep domain expertise in life sciences and future work technologies, valued for providing operational support and long-term capital to early-stage founders.12 Professionals note its focus on high-impact areas like cell therapies, positioning it as a strategic partner for European startups.14 Limited public commentary exists due to its niche focus and small team size.2